Evidence map›Paper›PMID 31866624›Full record

ReviewInternal medicine (Tokyo, Japan)2020

Pulmonary Mycobacterium parascrofulaceum Infection in a Patient with Chronic Progressive Pulmonary Aspergillosis: A Case Report and Literature Review.

Hiroaki Ikegami, Kei Yamasaki, Toshinori Kawanami, Kazumasa Fukuda, Kentaro Akata, Midori Nakamura, Issei Ikushima, Yoko Fukuda, Shingo Noguchi, Kazuhiro Yatera

Open access · diamondAbstract readCase ReportsReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Internal medicine (Tokyo, Japan), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Isolation and identification of non-tuberculous mycobacteria from aquarium fish in Ilam, Iran.Journal of clinical tuberculosis and other mycobacterial diseases · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Hiroaki IkegamiDepartment of Respiratory Medicine, University of Occupational and Environmental Health, Japan.
Kei YamasakiDepartment of Respiratory Medicine, University of Occupational and Environmental Health, Japan.
Toshinori KawanamiDepartment of Respiratory Medicine, University of Occupational and Environmental Health, Japan.
Kazumasa FukudaDepartment of Microbiology, University of Occupational and Environmental Health, Japan.
Kentaro AkataDepartment of Respiratory Medicine, University of Occupational and Environmental Health, Japan.
Midori NakamuraDepartment of Respiratory Medicine, University of Occupational and Environmental Health, Japan.
Issei IkushimaDepartment of Respiratory Medicine, University of Occupational and Environmental Health, Japan.
Yoko FukudaDepartment of Respiratory Medicine, University of Occupational and Environmental Health, Japan.
Shingo NoguchiDepartment of Respiratory Medicine, University of Occupational and Environmental Health, Japan.
Kazuhiro YateraDepartment of Respiratory Medicine, University of Occupational and Environmental Health, Japan.
University of Occupational and Environmental Health Japan · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 67-year-old man with a pulmonary cavity was admitted to our hospital. Mycobacterial culture of the bronchoalveolar lavage fluid sample obtained from the right upper pulmonary lesion tested positive for mycobacterium, and sequencing of the 16S rRNA genes, hsp65, and rpoB revealed that the cultured mycobacterium was Mycobacterium parascrofulaceum. Treatment with antimycobacterial agents was ineffective, and repeated culturing of bronchoscopic specimens revealed that the specimens were positive for Aspergillus fumigatus. Combination treatment of antimycobacterial agents and voriconazole improved the lung lesion. This is the first report of a patient with pulmonary M. parascrofulaceum infection complicated with chronic progressive pulmonary aspergillosis.

Indexed as

AdultAgedAnti-Bacterial AgentsAntifungal AgentsChronic DiseaseCoinfectionFemaleHumansMaleMiddle AgedMycobacterium InfectionsMycobacterium Infections, NontuberculousPulmonary AspergillosisTreatment OutcomeVoriconazoleAnti-Bacterial AgentsAntifungal AgentsVoriconazolechronic progressive pulmonary aspergillosisMycobacterium parascrofulaceumnontuberculous mycobacterium

Identifiers

PMID31866624
PMCPMC7332639
OpenAlexW2994893870

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.